Publication Name	World Journal of Hepatology
Manuscript ID	90516
Country	Israel

Received	2023-12-07 06:07
Peer-Review Started	2023-12-07 06:07
To Make the First Decision
Return for Revision	2024-02-03 02:47
Revised	2024-02-12 20:08
Second Decision	2024-04-25 02:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-25 08:30
Articles in Press	2024-04-25 08:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-28 00:40
Publish the Manuscript Online	2024-06-20 03:42

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology
Manuscript Source	Invited Manuscript
All Author List	Stephen David Howard Malnick and Doron Zamir
ORCID	Author(s) ORCID Number Stephen David Howard Malnick http://orcid.org/0000-0003-1865-8313
Funding Agency and Grant Number
Corresponding Author	Stephen David Howard Malnick, AGAF, MA, MBBS, MSc, Adjunct Associate Professor, Professor, Department of Internal Medicine C, Kaplan Medical Center, Rehov Pasternak, Rehovot 76100, Israel. stephen@malnick.net
Key Words	Non-alcoholic fatty liver disease; Steatosis metabolic-associated steatotic liver disease; Nomenclature
Core Tip	Due to the epidemic of obesity, there has been an increase in the prevalence of the metabolic syndrome and hepatic steatosis. The term non-alcoholic fatty liver disease (NAFLD) was given to describe the hepatic manifestation of the metabolic syndrome. Recently the nomenclature has been changed to metabolic dysfunction- associated steatotic liver disease. This removes stigmata associated with the term fatty and include a new entity reflecting both the metabolic syndrome and alcohol as causes of steatosis. These new terms do not alter the inclusion criteria for most of the published studies on NAFLD and will facilitate future studies.
Publish Date	2024-06-20 03:42
Citation	<p>Malnick SDH, Zamir D. From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology. <i>World J Hepatol</i> 2024; 16(6): 863-866</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i6/863.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i6.863

Full Article (PDF)	WJH-16-863-with-cover.pdf
Manuscript File	90516_Auto_Edited-YJP.docx
Answering Reviewers	90516-answering-reviewers.pdf
Audio Core Tip	90516-audio.m4a
Conflict-of-Interest Disclosure Form	90516-conflict-of-interest-statement.pdf
Copyright License Agreement	90516-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	90516-non-native-speakers.pdf
Peer-review Report	90516-peer-reviews.pdf
Scientific Editor Work List	90516-scientific-editor-work-list.pdf
CrossCheck Report	90516-crosscheck-report.pdf